VaxGen and Raven to merge

Two South San Francisco biotech firms, the struggling VaxGen and Raven biotechnologies, inc., have agreed to merge in an all-shares transaction.

Shareholders in VaxGen, which has suffered a series of well-publicised setbacks including the failure of an AIDS vaccine in 2003, delisting from Nasdaq in 2004 and the loss of a U.S. government anthrax vaccine contract in 2006, will retain a majority of shares in the new company, the company said in a statement released Monday. Vaxgen will also assume the privately-held Raven’s debt and equipment lease obligations of approximately $1.8 million, and move its headquarters to Raven’s offices.

Vaxgen is required as part of the merger to relist with a national stock exchange, a step that company officials said is underway.

The merged company’s board will include four Vaxgen board members and three Raven board members. Raven CEO George F. Schreiner will serve as CEO and director of the new company, with Vaxgen President and CEO James P. Panek to serve as president and chief operating officer.

The combined company will have one compound for major cancer indications in clinical development, four oncology product candidates in preclinical development, and a library of antibodies to novel cancer antigens, the companies said in a statement.

businessBusiness & Real Estate

If you find our journalism valuable and relevant, please consider joining our Examiner membership program.
Find out more at www.sfexaminer.com/join/

Just Posted

Ali Jamalian, whose life was disrupted in the wake of being charged with possession decades ago, now heads up Sunset Connect, a cannabis manufacturing company. (Kevin N. Hume/The Examiner)
Green Rush: Cannabis equity program elevates unexpected entrepreneurs

‘It’s a form of reparations for those of us who were ruined by cannabis arrest’

The Giants and Dodgers face each other again following a May series the Dodgers swept; Dodgers shortstop Gavin Lux caught stealing by Giants second baseman Donovan Solano at Oracle Park on May 23 is pictured. 
Chris Victorio/
Special to The Examiner
Giants vs. Dodgers: What you need to know before this week’s huge series

By Chris Haft Special to The Examiner That grinding noise you’ll hear… Continue reading

San Francisco supervisors approved zoning changes that will allow a chain grocery store to occupy the bottom floor of the 555 Fulton St. condo building. (Kevin N. Hume/The Examiner)
Trader Joe’s approved for Hayes Valley, bringing long-awaited grocery store

New Seasons Market canceled plans at 555 Fulton St. citing construction delays

Shek-Woon Ng, 107, who retired at 99 from his acupuncture practice in San Francisco’s Chinatown, got a COVID-19 vaccination in June. <ins>(Courtesy Sky Link TV)</ins>
Lesson from a 107-year-old man who is now fully vaccinated

One in four seniors in S.F.’s Chinatown have not been inoculated

Most Read